Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,628 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01889212 | Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC | terminated | N/A | 4 | University of AarhusOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT01941771 | Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer(XeNa) | completed | Phase 2 | 110 | University of AarhusOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT01021371 | The GP's Role in Cancer Rehabilitation: a Randomised, Controlled Study. | completed | Early Phase 1 | 959 | University of Southern DenmarkOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT01894256 | Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function | completed | Phase 1 | 56 | AstraZenecaINDUSTRY | 5 | Oct 13, 2016 | clinicaltrials |
| NCT02232685 | Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer | completed | N/A | 143 | Odense University HospitalOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT02266849 | Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study | terminated | Phase 3 | 12 | Odense University HospitalOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT02928120 | Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer | unknown | — | 658 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Oct 10, 2016 | clinicaltrials |
| NCT02141100 | Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma | withdrawn | Phase 1 / Phase 2 | 0 | Kjeld SchmiegelowOTHER | 1 | Oct 7, 2016 | clinicaltrials |
| NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 2,035 | Hoffmann-La RocheINDUSTRY | 33 | Oct 6, 2016 | clinicaltrials |
| NCT01889615 | Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer(Dual PETOvac) | unknown | — | 180 | Odense University HospitalOTHER | 1 | Oct 6, 2016 | clinicaltrials |
| NCT02433301 | PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy | completed | — | 23 | Rikshospitalet University HospitalOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT01538017 | Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture | completed | N/A | 50 | Jeppe Lange, MDOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00312377 | ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer(ZODIAC) | completed | Phase 3 | 1,690 | Genzyme, a Sanofi CompanyINDUSTRY | 25 | Sep 30, 2016 | clinicaltrials |
| NCT00861614 | Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 988 | Bristol-Myers SquibbINDUSTRY | 27 | Sep 30, 2016 | clinicaltrials |
| NCT00261365 | Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) | completed | Phase 1 / Phase 2 | 80 | Bristol-Myers SquibbINDUSTRY | 7 | Sep 29, 2016 | clinicaltrials |
| NCT00811135 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer | completed | Phase 2 | 88 | Hoffmann-La RocheINDUSTRY | 6 | Sep 29, 2016 | clinicaltrials |
| NCT00056407 | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk(REDUCE) | completed | Phase 3 | 8,231 | GlaxoSmithKlineINDUSTRY | 42 | Sep 23, 2016 | clinicaltrials |
| NCT02573935 | Clarithromycin in Multiple Myeloma Induction Therapy(CLAIM) | terminated | Phase 2 | 58 | Henrik GregersenOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02002468 | Follow-up of Abnormal and Inadequate Smear-test Results | unknown | N/A | 125,000 | University of AarhusOTHER | 1 | Sep 15, 2016 | clinicaltrials |
| NCT00169494 | Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 | completed | Phase 3 | 770 | GlaxoSmithKlineINDUSTRY | 6 | Sep 12, 2016 | clinicaltrials |
| NCT02880709 | The Effect of Special Diets in Hematological Cancer Patients | completed | Phase 4 | 32 | Jens Rikardt AndersenOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT02447237 | Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients | completed | N/A | 20 | Jens Rikardt AndersenOTHER | 1 | Aug 26, 2016 | clinicaltrials |
| NCT02880072 | Absorption of Orally Ingested Phosphate in Refeeding Syndrome | completed | Phase 4 | 12 | Jens Rikardt AndersenOTHER | 1 | Aug 26, 2016 | clinicaltrials |
| NCT00123474 | Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML | completed | Phase 3 | 724 | Bristol-Myers SquibbINDUSTRY | 31 | Aug 25, 2016 | clinicaltrials |
| NCT02527395 | Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia | completed | N/A | 121 | Rigshospitalet, DenmarkOTHER | 1 | Aug 25, 2016 | clinicaltrials |
| NCT01057810 | Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 837 | Bristol-Myers SquibbINDUSTRY | 24 | Aug 18, 2016 | clinicaltrials |
| NCT02252926 | Local Anesthetic Treatment of Oral Pain in Patients With Mucositis | completed | Phase 2 | 70 | Hvidovre University HospitalOTHER | 1 | Aug 16, 2016 | clinicaltrials |
| NCT02429128 | 14 Weeks Exercise Training on Lean Women With and Without PCOS | completed | N/A | 22 | University of CopenhagenOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT00162123 | A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies | completed | Phase 2 | 248 | Bristol-Myers SquibbINDUSTRY | 18 | Jul 27, 2016 | clinicaltrials |
| NCT00519285 | Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer(VENICE) | completed | Phase 3 | 1,224 | SanofiINDUSTRY | 31 | Jul 22, 2016 | clinicaltrials |
| NCT02240966 | Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors | completed | — | 200 | Rigshospitalet, DenmarkOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT02439073 | Postoperative Rehabilitation in Operation for LUng CAncer (PROLUCA)(PROLUCA) | unknown | N/A | 235 | Rigshospitalet, DenmarkOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01241396 | A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure | completed | — | 2,396 | Janssen Pharmaceutica N.V., BelgiumINDUSTRY | 21 | Jun 20, 2016 | clinicaltrials |
| NCT00785785 | A Study of Nilotinib Versus Imatinib in GIST Patients(ENESTg1) | completed | Phase 3 | 644 | Novartis PharmaceuticalsINDUSTRY | 35 | Jun 16, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT01588769 | A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients(ALECSAT-GBM) | completed | Phase 1 | 23 | CytoVac A/SINDUSTRY | 1 | Jun 6, 2016 | clinicaltrials |
| NCT02060955 | Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan | terminated | Phase 2 | 25 | CytoVac A/SINDUSTRY | 1 | Jun 6, 2016 | clinicaltrials |
| NCT01440088 | A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 640 | Threshold PharmaceuticalsINDUSTRY | 13 | Jun 2, 2016 | clinicaltrials |
| NCT01286077 | Velcade Consolidation Bone Study | completed | Phase 2 | 106 | Janssen-Cilag International NVINDUSTRY | 8 | May 30, 2016 | clinicaltrials |
| NCT00602745 | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen(S-1 Pancreas) | terminated | Phase 3 | 61 | SanofiINDUSTRY | 17 | May 26, 2016 | clinicaltrials |
| NCT02352623 | Quality of Life and Surgical Late Effects of Melanoma Treatment | completed | — | 435 | Herlev HospitalOTHER | 1 | May 26, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT00476541 | NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia | completed | Phase 3 | 250 | University of AarhusOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT01233544 | Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases(RAS01) | terminated | Phase 3 | 300 | University of AarhusOTHER | 2 | May 12, 2016 | clinicaltrials |
| NCT02583139 | Designed Music Narratives for the Reduction of Side Effects of Chemotherapy in Children (7-12 Years) With Cancer | unknown | N/A | 68 | University of AarhusOTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT01961180 | The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS | completed | Phase 4 | 42 | Odense University HospitalOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT00876044 | A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients(QUTIE) | completed | Phase 1 | 88 | SanofiINDUSTRY | 7 | May 5, 2016 | clinicaltrials |
| NCT00248170 | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer(FACE) | completed | Phase 3 | 4,172 | Novartis PharmaceuticalsINDUSTRY | 20 | Apr 19, 2016 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials